|
EN450
|
E610116-50mg
|
Moligand™, ≥98% |
793719-01-4 |
50mg
|
¥ 3699.9
|
现货 |
|
0 |
阿拉丁 |
|
EN450
|
E610116-1mg
|
Moligand™, ≥98% |
793719-01-4 |
1mg
|
¥ 329.9
|
现货 |
|
0 |
阿拉丁 |
|
EN450
|
E610116-10mg
|
Moligand™, ≥98% |
793719-01-4 |
10mg
|
¥ 1299.9
|
现货 |
|
0 |
阿拉丁 |
|
EN450
|
E610116-100mg
|
Moligand™, ≥98% |
793719-01-4 |
100mg
|
¥ 5299.9
|
现货 |
|
0 |
阿拉丁 |
|
Elubrixin
|
E610106-50mg
|
Moligand™, ≥98% |
688763-64-6 |
50mg
|
¥ 6249.9
|
现货 |
|
0 |
阿拉丁 |
|
Elubrixin
|
E610106-1mg
|
Moligand™, ≥98% |
688763-64-6 |
1mg
|
¥ 399.9
|
现货 |
|
0 |
阿拉丁 |
|
Elubrixin
|
E610106-10mg
|
Moligand™, ≥98% |
688763-64-6 |
10mg
|
¥ 1949.9
|
现货 |
|
0 |
阿拉丁 |
|
Elubrixin
|
E610106-100mg
|
Moligand™, ≥98% |
688763-64-6 |
100mg
|
¥ 9999.9
|
现货 |
|
0 |
阿拉丁 |
|
噁拉戈利
|
E610095-50mg
|
Moligand™, ≥95% |
834153-87-6 |
50mg
|
¥ 2699.9
|
现货 |
|
0 |
阿拉丁 |
|
噁拉戈利
|
E610095-10mg
|
Moligand™, ≥95% |
834153-87-6 |
10mg
|
¥ 1299.9
|
现货 |
|
0 |
阿拉丁 |
|
噁拉戈利
|
E610095-100mg
|
Moligand™, ≥95% |
834153-87-6 |
100mg
|
¥ 4299.9
|
现货 |
|
0 |
阿拉丁 |
|
离子交换树脂,Dowex 50WX2,50-100 (H)
|
D670237-5g
|
50WX2 50-100 (H) |
12612-37-2 |
5g
|
¥ 129.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
离子交换树脂,Dowex 50WX2,50-100 (H)
|
D670237-25g
|
50WX2 50-100 (H) |
12612-37-2 |
25g
|
¥ 469.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,2-二油酰基-sn-甘油-3-磷酸-L-丝氨酸(钠盐)(DOPS)
|
D669992-25mg
|
Moligand™, ≥98% |
90693-88-2 |
25mg
|
¥ 883.9
|
现货 |
|
0 |
阿拉丁 |
|
1,2-二油酰基-sn-甘油-3-磷酸-L-丝氨酸(钠盐)(DOPS)
|
D669992-10mg
|
Moligand™, ≥98% |
90693-88-2 |
10mg
|
¥ 446.9
|
现货 |
|
0 |
阿拉丁 |
|
1,2-二油酰基-sn-甘油-3-磷酸-L-丝氨酸(钠盐)(DOPS)
|
D669992-100mg
|
Moligand™, ≥98% |
90693-88-2 |
100mg
|
¥ 2399.9
|
现货 |
|
0 |
阿拉丁 |
|
快速DNA提取扩增试剂盒
|
D669986-50T
|
|
N/A |
50T
|
¥ 387.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[2-(diphenylmethyl)-1-azabicyclo[2.2.2]oct-3-ylidene]-1-(2-methoxyphenyl)-ethanone
|
D669868-250mg
|
|
887109-77-5 |
250mg
|
¥ 3880.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-[2-(diphenylmethyl)-1-azabicyclo[2.2.2]oct-3-ylidene]-1-(2-methoxyphenyl)-ethanone
|
D669868-100mg
|
|
887109-77-5 |
100mg
|
¥ 1940.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-(2,2-difluoro-1,3-benzodioxol-4-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethyl-ethyl)indol-5-yl]cyclopropanecarboxamide
|
D669864-250mg
|
|
1419101-35-1 |
250mg
|
¥ 17592.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-(2,2-difluoro-1,3-benzodioxol-4-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethyl-ethyl)indol-5-yl]cyclopropanecarboxamide
|
D669864-100mg
|
|
1419101-35-1 |
100mg
|
¥ 10552.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide
|
D669849-250mg
|
|
2446816-88-0 |
250mg
|
¥ 10936.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide
|
D669849-100mg
|
|
2446816-88-0 |
100mg
|
¥ 6560.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1-[4-[4-[[2-(2,4-difluorophenyl)-2-methyl-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
|
D669846-250mg
|
|
1186622-98-9 |
250mg
|
¥ 3840.9
|
期货,请咨询 |
|
0 |
阿拉丁 |